Multiple sources are pointing to a new report that Merck paid Elsevier, a leading publisher, to produce several volumes of the Australasian Journal of Bone and Joint Medicine, which appeared to be a peer-reviewed journal, but was really little more than marketing material for the pharmaceutical company.
Merck and Elsevier Published Fake Journal
May 4, 2009
Share this post
2 Comments

Law Bytes
Episode 280: A Fall Update on Where Things Stand on Canadian Digital Policy Reforms
byMichael Geist

October 26, 2026
Michael Geist
October 19, 2026
Michael Geist
August 10, 2026
Michael Geist
Search Results placeholder
Michael Geist on Substack
Recent Posts
The Law Bytes Podcast, Episode 280: A Fall Update on Where Things Stand on Canadian Digital Policy Reforms
The Wrong Ban: The Heritage Committee Backed a Targeted Ad Ban for Kids and Stopped Short of a Social Media Ban, Yet the Government Chose the Reverse
Regulator First, Rules Later: Bill C-34 Debate Shows the Government Wants a Digital Safety Commission Before It Figures Out What It Will Do
Making the Case Against Its Own Bill: What the Government’s Bill C-34 Charter Statement Reveals About the Constitutional Vulnerability of the Social Media Ban
“Position Has Not Changed”: The Canadian Government Reaffirms That Antisemitism Includes Anti-Zionism

And educational institutions subscribe to Elsevier ScienceDirect
1. Publish a fake journal with Elsevier and the like
2. Make educational institurions subscribe to Elsevier and the like
3. Tie university professors with Big Pharma
4. PROFIT!
Regarding [3], visit http://www.ahrp.org/cms/content/view/523/9/
Harvard Medical Students Rebel Against Big Pharma
“The students say they worry that pharmaceutical industry scandals in recent years – including some criminal convictions, billions of dollars in fines, proof of bias in research and publishing and false marketing claims – have cast a bad light on the medical profession. And they criticize Harvard as being less vigilant than other leading medical schools in monitoring potential financial conflicts by faculty members.”
Marketing material, yes, but…
The info that the publication was paid for by Merck could be inferred, if you took the time. In the item pointed to, the ONLY advertisements were from Merck (at least that was the only ones that I noticed).
However, I’d agree that it should have been specifically mentioned. Sort of like the “Medi-Facts” commercials airing these days.